LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

PHASE3RecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2028

Conditions
Pulmonary Hypertension
Interventions
DRUG

TNX-103

oral levosimendan 1 mg

DRUG

Placebo

Placebo

Trial Locations (54)

10021

RECRUITING

Tenax Investigational Site, New York

10029

RECRUITING

Tenax Investigational Site, New York

11576

RECRUITING

Tenax Investigational Site, Roslyn

14621

RECRUITING

Tenax Investigational Site, Rochester

15212

RECRUITING

Tenax Investigational Site, Pittsburgh

19140

RECRUITING

Tenax Investigational Site, Philadelphia

20010

RECRUITING

Tenax Investigational Site, Washington D.C.

23298

RECRUITING

Tenax Investigational Site, Richmond

27401

RECRUITING

Tenax Investigational Site, Greensboro

27710

RECRUITING

Tenax Investigational Site, Durham

28203

RECRUITING

Tenax Investigational Site, Charlotte

29425

RECRUITING

Tenax Investigational Site, Charleston

29605

RECRUITING

Tenax Investigational Site, Greenville

30322

RECRUITING

Tenax Investigational Site, Atlanta

32224

RECRUITING

Tenax Investigational Site, Jacksonville

33601

RECRUITING

Tenax Investigational Site, Tampa

33612

RECRUITING

Tenax Investigational Site, Tampa

33881

RECRUITING

Tenax Investigational Site, Winter Haven

35233

RECRUITING

Tenax Investigational Site, Birmingham

37232

RECRUITING

Tenax Investigational Site, Nashville

40202

RECRUITING

Tenax Investigational Site, Louisville

43214

RECRUITING

Tenax Investigational Site, Columbus

45267

RECRUITING

Tenax Investigational Site, Cincinnati

46202

RECRUITING

Tenax Investigational Site, Indianapolis

46260

RECRUITING

Tenax Investigational Site, Indianapolis

53792

RECRUITING

Tenax Investigational Site, Madison

55455

RECRUITING

Tenax Investigational Site, Minneapolis

55905

RECRUITING

Tenax Investigational Site, Rochester

60208

RECRUITING

Tenax Investigational Site, Chicago

60453

RECRUITING

Tenax Investigational Site, Oak Lawn

60637

RECRUITING

Tenax Investigational Site, Chicago

61401

RECRUITING

Tenax Investigational Site, Galesburg

63136

RECRUITING

Tenax Investigational Site, St Louis

66160

RECRUITING

Tenax Investigational Site, Kansas City

68198

RECRUITING

Tenax Investigational Site, Omaha

72205

RECRUITING

Tenax Investigational Site, Little Rock

75093

RECRUITING

Tenax Investigational Site, Plano

75204

RECRUITING

Tenax Investigational Site, Dallas

75390

RECRUITING

Tenax Investigational Site, Dallas

79430

RECRUITING

Tenax Investigational Site, Lubbock

84107

RECRUITING

Tenax Investigational Site, Murray

85721

RECRUITING

Tenax Investigational Site, Tucson

90033

RECRUITING

Tenax Investigational Site, Los Angeles

90048

RECRUITING

Tenax Investigational Site, Los Angeles

90502

RECRUITING

Tenax Investigational Site, Torrance

92037

RECRUITING

Tenax Investigational Site, La Jolla

92868

RECRUITING

Tenax Investigational Site, Irvine

94143

RECRUITING

Tenax Investigational Site, San Francisco

95817

RECRUITING

Tenax Investigational Site, Sacramento

02114

RECRUITING

Tenax Investigational Site, Boston

02903

RECRUITING

Tenax Investigational Site, Providence

Unknown

RECRUITING

Tenax Investigational Site, Winnipeg

N6A 5A5

RECRUITING

Tenax Investigational Site, London

M5A 4P5

RECRUITING

Tenax Investigational Site, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medpace, Inc.

INDUSTRY

collaborator

Northwestern University

OTHER

lead

Tenax Therapeutics, Inc.

INDUSTRY